| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of 1 Cell and Developmental Biology, 2 Cancer Biology, and 3 Medicine (Nephrology), Vanderbilt University School of Medicine, Nashville, Tennessee
Requests for reprints: Steven K. Hanks, Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37212. Phone: 615-343-8502. E-mail: steve.hanks{at}vanderbilt.edu
Crk-associated substrate (CAS, p130Cas) is a major tyrosine phosphorylated protein in cells transformed by v-crk and v-src oncogenes. We recently reported that reexpression of CAS in CAS-deficient mouse embryo fibroblasts transformed by oncogenic Src promoted an invasive phenotype associated with enhanced cell migration through Matrigel, organization of actin into large podosome ring and belt structures, activation of matrix metalloproteinase-2, and elevated tyrosine phosphorylation of the focal adhesion proteins FAK and paxillin. We have now extended these studies to examine the mechanism by which CAS achieves these changes and to evaluate the potential role for CAS in promoting in vivo tumor growth and metastasis. Whereas the presence or absence of CAS did not alter the primary growth of subcutaneous-injected Src-transformed mouse embryo fibroblasts, CAS expression was required to promote lung metastasis following removal of the primary tumor. The substrate domain YxxP tyrosines, the major sites of CAS phosphorylation by Src that mediate interactions with Crk, were found to be critical for promoting both invasive and metastatic properties of the cells. The ability of CAS to promote Matrigel invasion, formation of large podosome structures, and tyrosine phosphorylation of Src substrates, including FAK, paxillin, and cortactin, was also strictly dependent on the YxxP tyrosines. In contrast, matrix metalloproteinase-2 activation was most dependent on the CAS SH3 domain, whereas the substrate domain YxxP sites also contributed to this property. Thus multiple CAS-mediated signaling events are implicated in promoting invasive and metastatic properties of Src-transformed cells.
This article has been cited by other articles:
|
|
 |
|
  S. I. Park, J. Zhang, K. A. Phillips, J. C. Araujo, A. M. Najjar, A. Y. Volgin, J. G. Gelovani, S.-J. Kim, Z. Wang, and G. E. Gallick Targeting Src Family Kinases Inhibits Growth and Lymph Node Metastases of Prostate Cancer in an Orthotopic Nude Mouse Model Cancer Res., May 1, 2008; 68(9): 3323 - 3333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Badowski, G. Pawlak, A. Grichine, A. Chabadel, C. Oddou, P. Jurdic, M. Pfaff, C. Albiges-Rizo, and M. R. Block Paxillin Phosphorylation Controls Invadopodia/Podosomes Spatiotemporal Organization Mol. Biol. Cell, February 1, 2008; 19(2): 633 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Stuart, S. A. Bell, C. R. Stewart, J. M. Silver, J. Richard, J. L. Goss, A. A. Tseng, A. Zhang, J. B. E. Khoury, and K. J. Moore CD36 Signals to the Actin Cytoskeleton and Regulates Microglial Migration via a p130Cas Complex J. Biol. Chem., September 14, 2007; 282(37): 27392 - 27401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Schrecengost, R. B. Riggins, K. S. Thomas, M. S. Guerrero, and A. H. Bouton Breast Cancer Antiestrogen Resistance-3 Expression Regulates Breast Cancer Cell Migration through Promotion of p130Cas Membrane Localization and Membrane Ruffling Cancer Res., July 1, 2007; 67(13): 6174 - 6182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shen, P. R. Khusial, X. Li, H. Ichikawa, A. P. Moreno, and G. S. Goldberg Src Utilizes Cas to Block Gap Junctional Communication Mediated by Connexin43 J. Biol. Chem., June 29, 2007; 282(26): 18914 - 18921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Clark, A. S. Whigham, W. G. Yarbrough, and A. M. Weaver Cortactin Is an Essential Regulator of Matrix Metalloproteinase Secretion and Extracellular Matrix Degradation in Invadopodia Cancer Res., May 1, 2007; 67(9): 4227 - 4235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Liu, W. Li, X. Gao, X. Li, C. Jurgensen, H.-T. Park, N.-Y. Shin, J. Yu, M.-L. He, S. K. Hanks, et al. p130CAS Is Required for Netrin Signaling and Commissural Axon Guidance J. Neurosci., January 24, 2007; 27(4): 957 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ogden, J. M. Thompson, Z. Hickner, T. Huang, D. D. Tang, and S. W. Watts A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2857 - H2863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Patwardhan, Y. Shen, G. S. Goldberg, and W. T. Miller Individual Cas Phosphorylation Sites Are Dispensable for Processive Phosphorylation by Src and Anchorage-independent Cell Growth J. Biol. Chem., July 28, 2006; 281(30): 20689 - 20697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M.F. Siesser and S. K. Hanks The Signaling and Biological Implications of FAK Overexpression in Cancer. Clin. Cancer Res., June 1, 2006; 12(11): 3233 - 3237. [Full Text] [PDF]
|
|
|
|
|
|
Y. Shen, Z. Jia, R. G. Nagele, H. Ichikawa, and G. S. Goldberg Src Uses Cas to Suppress Fhl1 in Order to Promote Nonanchored Growth and Migration of Tumor Cells Cancer Res., February 1, 2006; 66(3): 1543 - 1552. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
